The global metabolism assay market is set to expand at an 8.1% CAGR from 2024 to 2034, increasing from US$ 1.7 billion to US$ 3.6 billion. This growth is fueled by the rising prevalence of metabolic disorders like diabetes and obesity, which are propelling the demand for personalized medicine and targeted therapies enabled by metabolism assays. Advances in metabolic genetics and pharmacogenomics are enhancing research efforts and adoption within various healthcare sectors, with innovative cellular metabolism assay technologies driving market growth.

Metabolism Assay Market Surges Ahead